Peachtree Investment Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.1M | Sell |
21,737
-41
| -0.2% | -$41.9K | 8.36% | 2 |
|
|
2026
Q1 | $20M | Sell |
21,778
-909
| -4% | -$922K | 7.63% | 3 |
|
|
2025
Q4 | $24.4M | Sell |
22,687
-135
| -0.6% | -$129K | 8.09% | 3 |
|
|
2025
Q3 | $17.4M | Sell |
22,822
-1,306
| -5% | -$972K | 6.04% | 4 |
|
|
2025
Q2 | $18.8M | Sell |
24,128
-808
| -3% | -$628K | 7.18% | 3 |
|
|
2025
Q1 | $20.6M | Sell |
24,936
-691
| -3% | -$575K | 8.14% | 3 |
|
|
2024
Q4 | $19.8M | Sell |
25,627
-1,984
| -7% | -$1.64M | 7.41% | 3 |
|
|
2024
Q3 | $24.5M | Sell |
27,611
-197
| -0.7% | -$177K | 9.2% | 3 |
|
|
2024
Q2 | $25.2M | Buy |
27,808
+43
| +0.2% | +$34.4K | 9.88% | 3 |
|
|
2024
Q1 | $21.6M | Sell |
27,765
-2,720
| -9% | -$1.94M | 8.73% | 3 |
|
|
2023
Q4 | $17.8M | Sell |
30,485
-898
| -3% | -$524K | 7.29% | 3 |
|
|
2023
Q3 | $16.9M | Buy |
31,383
+6,169
| +24% | +$3.18M | 8.6% | 3 |
|
|
2023
Q2 | $11.8M | Buy |
25,214
+14,298
| +131% | +$6M | 5.4% | 4 |
|
|
2023
Q1 | $3.75M | Sell |
10,916
-6,887
| -39% | -$2.32M | 2.34% | 12 |
|
|
2022
Q4 | $6.51M | Buy |
17,803
+3,883
| +28% | +$1.38M | 3.98% | 5 |
|
|
2022
Q3 | $4.5M | Buy |
13,920
+1,013
| +8% | +$321K | 3.02% | 8 |
|
|
2022
Q2 | $4.18M | Buy |
12,907
+6,608
| +105% | +$1.98M | 2.61% | 8 |
|
|
2022
Q1 | $1.8M | Sell |
6,299
-202
| -3% | -$52K | 0.83% | 26 |
|
|
2021
Q4 | $1.8M | Buy |
6,501
+1,304
| +25% | +$331K | 0.75% | 28 |
|
|
2021
Q3 | $1.2M | Buy |
5,197
+350
| +7% | +$86.4K | 0.59% | 32 |
|
|
2021
Q2 | $1.11M | Sell |
4,847
-219
| -4% | -$44K | 0.54% | 33 |
|
|
2021
Q1 | $946K | Buy |
5,066
+437
| +9% | +$85.5K | 0.54% | 34 |
|
|
2020
Q4 | $782K | Buy |
4,629
+30
| +0.7% | +$4.48K | 0.46% | 35 |
|
|
2020
Q3 | $681K | Buy |
+4,599
| New | +$712K | 0.47% | 36 |
|
|
2020
Q2 | – | Sell |
-4,510
| Closed | -$625K | – | 76 |
|
|
2020
Q1 | $625K | Sell |
4,510
-293
| -6% | -$40.3K | 0.63% | 26 |
|
|
2019
Q4 | $631K | Sell |
4,803
-1,589
| -25% | -$184K | 0.44% | 38 |
|
|
2019
Q3 | $715K | Sell |
6,392
-2,200
| -26% | -$245K | 0.57% | 35 |
|
|
2019
Q2 | $952K | Sell |
8,592
-13,401
| -61% | -$1.58M | 0.75% | 27 |
|
|
2019
Q1 | $2.85M | Buy |
21,993
+11,026
| +101% | +$1.34M | 2.41% | 15 |
|
|
2018
Q4 | $1.27M | Buy |
+10,967
| New | +$1.23M | 1.44% | 19 |
|
Other funds holding LLY
Peachtree Investment Partners's LLY Position: Q2 2026 in Review
Peachtree Investment Partners reduced its Eli Lilly (LLY) stake by 0.19% in Q2 2026, selling an estimated $41.9K and leaving 21,737 shares worth $26.1M. The position accounts for 8.36% of the portfolio, ranked #2.
Peachtree Investment Partners first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Peachtree Investment Partners held 21,737 shares of Eli Lilly worth $26.1M as of Q2 2026.
- Peachtree Investment Partners sold 41 Eli Lilly shares in Q2 2026, an estimated $41.9K.
- Eli Lilly made up 8.36% of Peachtree Investment Partners's portfolio in Q2 2026, its #2 holding.
- Peachtree Investment Partners first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Peachtree Investment Partners's 13F filing for Q2 2026, filed 6 Aug 2026.